Patient Case Records Review

Similar documents
Theradex Audit 2013: Findings & Corrective Action

QUALITY ASSURANCE PROGRAM

The GCP Perspective on Study Monitoring

SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

VCU Clinical Research Quality Assurance Assessment

Subject Research Records. Essential Regulatory and Source Documents. Subject Research Records. Regulatory Files

REGISTERING A PATIENT

Good Clinical Practice: A Ground Level View

TITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18

WIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)

Risk-Benefit Ratio and Determinations. Sarah Mumford, Ammon Pate, Annie Risenmay IRB Operations Managers University of Utah

4.7 Quality Study. Study Title: Intervention to Improve Safe, Effective And Timely Oral Chemotherapy Administration and Documentation

Checklist prior to recruiting first patient

MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: MCCCRO-D

Mastering Clinical Research April 19, :30 am

Section 2 Medication Orders

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

SUMMARY OF CHANGES Amendment 7, Version Date: March 24, 2010 (Broadcast 4/6/10)

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

Good Documentation Practices. Human Subject Research. for

ASCO s Quality Training Program

Yes. Phone encounter? Part of screening process. Consent and enroll patient. Apply Treatment Plan. Verify link to Timeline. Conduct patient assessment

Centralized Office of Research

PROMPTLY REPORTABLE EVENTS

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

Version 4 January 18, Principal Investigator: James F. Marion, M.D. The Mount Sinai School of Medicine

4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.

Study Monitoring Plan Template

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

ACRIN ADVERSE EVENT REPORTING MANUAL. 1 March 2006 v.3

Hospital-wide Lean Project:

Mastering Clinical Research

CONTINUING NON-COMPLIANCE

STUDY TEAM RESPONSIBILITIES ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2

Prepared by the American College of Radiology Imaging Network Protocol Development and Regulatory Compliance Department

Section II: Food Service. MPR 1 Plan Review

The presenter has owns Kelly Willenberg, LLC in relation to this educational activity.

Building Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies

RITAZAREM CRF Completion Guidelines

managing or activities.

Human Subject Regulations Decision Charts

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

EMA Inspection Site perspective

I. Scope This policy defines unanticipated problems and adverse events and establishes the reporting process and timeline.

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

GCP INSPECTION CHECKLIST

ORAL ANTI-CANCER THERAPY POLICY

Clinical Trial Quality Assurance Common Findings

20 STEPS FROM STUDY IDEA INCEPTION TO PUBLISHING RESEARCH/ Evidence-Based Practice

QUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES

BIMO SITE AUDIT CHECKLIST

Essential Documents It s Not Just a Binder!

Section 9. Study Product Considerations for Non- Pharmacy Staff

Oncology Quick Start Guide

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

Subject Screening, Recruitment, and Retention. Tiffany Morrison, MS, CCRP Director, Clinical Trials Rothman Institute

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

Medicine Reconciliation FREQUENTLY ASKED QUESTIONS NATIONAL MEDICATION SAFETY PROGRAMME

Purpose. Background. Frequency and Scheduling of Post Payment Reviews

UConn Health Office of Clinical & Translational Research Standard Operating Procedures

DANA-FARBER / HARVARD CANCER CENTER STANDARD OPERATING PROCEDURES FOR HUMAN SUBJECT RESEARCH

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

Improving Patient Care through. Clinical Audit. A How To Guide

Introduction to the United States Food and Drug Administration (FDA) and FDA Inspection Process VOICE

General Administration GA STANDARD OPERATING PROCEDURE FOR Document Development and Change Control

Audits/Inspections Be Prepared for Anything

ONADE s Data Quality Review

6. BASELINE ACTIVITIES. 6.1 Summary of Evaluations Performed During the Baseline Period

Study Management PP STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist

PLATELET-ORIENTED INHIBITION ISCHEMIC STROKE (POINT) MONITORING PLAN IN NEW TIA AND MINOR. Version 2.0 Updated 11 May 2017

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

1.2.1 It is the policy of the University of Alabama that qualifying research may be reviewed using an expedited procedure.

Aged residential care (ARC) Medication Chart implementation and training guide (version 1.1)

Data Quality Tools: SWOG Expectation Reports and CTSU Data Quality Portal

Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that

IN ACCORDANCE WITH THIS INTERNATIONAL DEVICE STANDARD

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

How can oncology practices deliver better care? It starts with staying connected.

Inspections, Compliance, Enforcement, and Criminal Investigations

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

Documentation: Protect Your Patient/Protect Yourself. Presented by Laura Iding RN, BSN, MBA, CPHRM Director Risk Management September 11, 2013

Please place your phone line on mute.

Local VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB

11/18/2016. UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities SESSION 4

Comprehensive Protocol Feasibility Questionnaire

DEPARTMENT OF HEALTH & HUMAN SERVICES WARNING LETTER. (b) (4) clinical investigation (Protocol entitled A Phase II, Multicenter,

Agency for Health Care Administration

DO I NEED TO SUBMIT FOR THIS?... & OTHER FREQUENTLY ASKED QUESTIONS. March 2015 IRB Forum

Revised: August 2017 Effective: 6 September 2017 TABLE OF CONTENTS

CLINICAL RESEARCH BILLING 101

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

5/1/2017 THE BEST DEFENSE IS A GOOD OFFENSE OBJECTIVES. Preparing for a Home Health Medicare Recertification Survey

Vascular Surgery Academic Coordinating Center (VSACC) & Peripheral Vascular Core Lab (PVCL)

Transcription:

Patient Case Records Review Debra Herzan, RN, BSN, OCN, CCRP Alliance for Clinical Trials in Oncology Audit Prep Workshop - Alliance Group Meeting November, 2014

6 Categories l Informed Consent l Eligibility l Treatment l Disease Outcome/Response l Adverse Events/Study Parameters l General Data Quality

Informed Consent l Participant signed, dated prior to undergoing any study related procedures l All required signatures are present l Current, IRB-approved CF was used l Any required re-consents l Non English speaking subjects

Eligibility l Documentation that all eligibility criteria have been met as specified by the protocol l All required tests to confirm eligibility were performed prior to randomization l Tests done within protocol time limits

Treatment l Specific protocol treatment was given l Treatment given per protocol timeframe l Dose Deviations/Modifications l Additional agent/treatment given?

Disease Outcome/Response l Accurate documentation of initial sites of involvement l Re-evaluation of status performed according to protocol l Protocol-directed response criteria followed l Verify claimed response (PR, CR)

Toxicity/Study Parameters l Follow-up studies necessary to assess toxicities were performed l Grades, types, and attribution of toxicities accurately recorded l Adverse Event Expedited Reporting filed for required toxicity (CTEP-AERs)

General Data Quality l Data accurately reported on CRFs l Forms complete l Data submitted in a timely manner l Concordance with source documentation l Supplemental reports l Specimens

Source Documents: ALCOA Attributable: is it obvious who wrote it? Legible: can it be read? Contemporaneous: is the information current and in the correct time frame? Original: is it a copy; has it been altered? Accurate: are conflicting data recorded elsewhere? *Source: The Facts About Source Documents by Stan W. Woollen, Presented at the 1999 DIA Annual Meeting

Preparing for an Audit l Ensure that arrangements have been made: l Reserve conference room l Notify appropriate personnel l Request all required materials l Ensure Principal Investigator available l Review your records!

Pt. ID

What is a Major Deficiency CTMB Guidelines Section 5.4.1 l l l A variance from protocol-specific procedures that makes the resulting data questionable. Anything that could affect patient safety. An unacceptable frequency of lesser deficiencies may be treated as a major deficiency.

What is a Lesser Deficiency CTMB Guidelines Section 5.4.2 l A deficiency that is judged not to have a significant impact on the outcome or interpretation of the study and is not described as a major deficiency.

OK, Lesser or Major? l Patient Case Review Informed Consent Consent form used was not the current IRB-approved version at the time of patient registration; the correct version was signed 1 week after registration.

Ok, Lesser or Major? l Patient Case Review Eligibility A pregnancy test was not done prerandomization in this documented premenopausal patient. There was no documentation regarding sexual activity and/or use of contraceptives. Of note, a pregnancy test done after randomization but before treatment was negative.

Ok, Lesser or Major? l Patient Case Review Eligibility The physician signed and dated an eligibility checklist indicating that all eligibility criteria are met. The required hemoglobin is >9.0 gm/dl, but the lab result printout indicates the hemoglobin is 8.9 gm/dl.

Ok, Lesser or Major? l Patient Case Review Treatment Carboplatin dose given was 760 mg, but calculated dose was 693 mg.

Ok, Lesser or Major? l Patient Case Review Treatment Patient was given IV Dexamethasone instead of oral Dexamethasone as a premed for cycle 1.

Ok, Lesser or Major? l Patient Case Review Treatment Documentation of patient counseling for lenalidomide was done at baseline, but not at the monthly dispensing of agent as required per Section 10.6.

Ok, Lesser or Major? l Patient Case Review Adverse Event/Study Parameters TSH/T4 levels were not checked at the required timepoints of 6 months, 12 months and post treatment.

Ok, Lesser or Major? l Patient Case Review Adverse Event/Study Parameters A CTEP-AERs report (expedited adverse event reporting) was not submitted for cycle 1 hospitalization due to neutropenic fever.

Ok, Lesser or Major? l Patient Case Review Adverse Event/Study Parameters Scan reports were not available for auditors to review. Unable to confirm reported date of progression.

Ok, Lesser or Major? l Patient Case Review Adverse Event/Study Parameters The subject has been non-compliant with follow-up visits. There is good documentation of clinic scheduling and attempts to contact the subject.

Ok, Lesser or Major? l Patient Case Review General Data Quality The eligibility form due at baseline (10/19/13) was submitted 3/12/14 (3-6 months late).

Ok, Lesser or Major? l Patient Case Review General Data Quality The reported baseline value of AST is 43, but source documentation indicates value should be 53.

Ok, Lesser or Major? l Patient Case Review General Data Quality The frozen specimens due at baseline were not submitted to the Pathology Coordinating Office by the time of the audit, 2 years later.

Common Findings l Informed Consent l Re-consenting not done l Blanks remain blank l Eligibility l Performance status not documented l Tests done out of window l Treatment: l Oral compliance not documented l Dose modifications not done or not within requirements of the protocol

Common Findings l Disease Outcome/Response l All initial sites of disease not reported at baseline l New sites of disease not reported l Adverse Events/Study Parameters l Toxicity assessments not performed or inconsistent l Unnecessary reporting of AEs < grade 3 l General Data Quality l Corrections not done correctly l Delinquent data

Component Evaluation CTMB Guidelines Section 5.4.3 l Acceptable l No Major deficiencies found during the audit l Acceptable needs follow-up l One or more major deficiencies found l Unacceptable l Multiple Major deficiencies or flagrant deficiencies found (re-audit required)

Want an easier audit day? l Document! l If it is not documented, it did not happen l Communicate! l Don t be afraid to ask questions l Keep records audit ready l Tag paper charts or keep summary sheet for electronic records as you go along

Questions?

2014 Fall Group Meeting November 5 8 / Chicago, IL